{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:10:24Z","timestamp":1789737024260,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.gyobfe.2013.11.006","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T21:02:23Z","timestamp":1389128543000},"page":"325-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bilan d\u2019extension des cancers du sein\u00a0: r\u00e9sultats et cons\u00e9quences cliniques"],"prefix":"10.1016","volume":"42","author":[{"given":"A.","family":"Turpin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mailliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vennin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bonneterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a06","key":"10.1016\/j.gyobfe.2013.11.006_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/annonc\/mdr371","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Aebi","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.rcl.2004.06.014","article-title":"The randomized trials of breast cancer screening: what have we learned?","volume":"42","author":"Smith","year":"2004","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.6004\/jnccn.2011.0016","article-title":"Invasive breast cancer","volume":"9","author":"Carlson","year":"2011","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0020","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1200\/JCO.2005.01.6089","article-title":"Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer","volume":"24","author":"Lohrisch","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.breast.2011.10.005","article-title":"Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer","volume":"21","author":"Brennan","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1524-4741.2010.00987.x","article-title":"Additional value of PET-CT in staging of clinical stage IIB and III breast cancer","volume":"16","author":"Segaert","year":"2010","journal-title":"Breast J"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0035","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1200\/JCO.2008.17.1496","article-title":"Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography\/computed tomography compared with conventional imaging procedures","volume":"26","author":"Fuster","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejso.2011.09.002","article-title":"The value of 18-FDG PET\/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan","volume":"38","author":"Garami","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0045","first-page":"1819","article-title":"Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET","volume":"46","author":"Kumar","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0050","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2967\/jnumed.111.093864","article-title":"The yield of 18F-FDG PET\/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study","volume":"52","author":"Groheux","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0055","first-page":"135","article-title":"The role of (18)F-FDG PET\/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging","volume":"14","author":"Mittal","year":"2011","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7150\/jca.1.51","article-title":"The role of F-FDG-positron emission tomography\/computed tomography in staging primary breast cancer","volume":"1","author":"Niikura","year":"2010","journal-title":"J Cancer"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.2004.04.148","article-title":"Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group","volume":"22","author":"Wahl","year":"2004","journal-title":"J Clin Oncol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.gyobfe.2013.11.006_bib0070","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1148\/rg.27si075517","article-title":"FDG PET, PET\/CT, and breast cancer imaging","volume":"27","author":"Rosen","year":"2007","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.gyobfe.2013.11.006_bib0075","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00259-012-2077-0","article-title":"Whole-body FDG PET\/CT is more accurate than conventional imaging for staging primary breast cancer patients","volume":"39","author":"Riegger","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00404-002-0445-x","article-title":"Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation","volume":"269","author":"Schneider","year":"2003","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jjco\/hye049","article-title":"What do breast cancer patients benefit from staging bone scintigraphy?","volume":"31","author":"Koizumi","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0090","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","article-title":"Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions","volume":"16","author":"Cook","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0095","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta15180","article-title":"An economic evaluation of positron emission tomography (PET) and positron emission tomography\/computed tomography (PET\/CT) for the diagnosis of breast cancer recurrence","volume":"15","author":"Auguste","year":"2011","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-011-1767-9","article-title":"18F-FDG PET\/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques","volume":"131","author":"Koolen","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11307-005-0012-5","article-title":"Cost-effectiveness of positron emission tomography in breast cancer","volume":"7","author":"Sloka","year":"2005","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3348\/kjr.2007.8.5.429","article-title":"The role of PET\/CT for evaluating breast cancer","volume":"8","author":"Yang","year":"2007","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.gyobfe.2013.11.006_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15350","article-title":"The value of FDG positron emission tomography\/computerised tomography (PET\/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation","volume":"15","author":"Brush","year":"2011","journal-title":"Health Technol Assess"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958913003676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958913003676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T13:36:46Z","timestamp":1597325806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958913003676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1297958913003676"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2013.11.006","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilan d\u2019extension des cancers du sein\u00a0: r\u00e9sultats et cons\u00e9quences cliniques","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gyobfe.2013.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}